Yamamoto, K., Takeda, K., & Maeda, H. Retrospective Analysis of Master Protocols in Tumor‐Agnostic Drug Development: Evaluation of Application to Single‐Agent Therapies With ORR as the Endpoint for Approval of Oncology Drugs. Wiley.
Chicago Style (17th ed.) CitationYamamoto, Keiko, Kentaro Takeda, and Hideki Maeda. Retrospective Analysis of Master Protocols in Tumor‐Agnostic Drug Development: Evaluation of Application to Single‐Agent Therapies With ORR as the Endpoint for Approval of Oncology Drugs. Wiley.
MLA (9th ed.) CitationYamamoto, Keiko, et al. Retrospective Analysis of Master Protocols in Tumor‐Agnostic Drug Development: Evaluation of Application to Single‐Agent Therapies With ORR as the Endpoint for Approval of Oncology Drugs. Wiley.
Warning: These citations may not always be 100% accurate.